×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
SAS Institute, JMP Division Innovation Theater: RECIST Criteria and Their Impact on Safety and Efficacy Reporting in Oncology Studies
Session Chair(s)
JMP Statistical Discovery
JMP, A Business Unit of SAS, United States
Response evaluation criteria in solid tumors (RECIST) define whether patients in oncology studies are improving, stable or worsening during treatment. These criteria have a direct impact on visualizations such as Swimmer Plots, Spider Plots and Progression Free Survival. Additionally, they create complexity when creating Serious Adverse Event Narratives. Join us and learn how JMP Clinical handles all of these issues and more.
Speaker(s)
Geoff Mann, PhD
JMP Statistical Discovery, United States
Advanced Analytics Manager
Have an account?